Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
Farmers Insurance
UBS
Chinese Patent Office
Fuji
Chubb
Medtronic
Cerilliant

Generated: May 27, 2018

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has sixty-four approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms
US Patents:0
Tradenames:51
Ingredients:50
NDAs:64

Drugs and US Patents for Glenmark Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Inc LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 091544-001 Dec 27, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Ltd ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079019-003 May 30, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Ltd TELMISARTAN telmisartan TABLET;ORAL 090032-001 Jul 7, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
AstraZeneca
McKinsey
Argus Health
Deloitte
QuintilesIMS
Cipla
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.